ACAD logo

ACADIA Pharmaceuticals (ACAD) Cash From Investing

Annual CFI

-$30.54 M
-$62.54 M-195.44%

December 31, 2024


Summary


Performance

ACAD Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACADcash flowmetrics:

Quarterly CFI

$122.15 M
+$204.61 M+248.14%

December 31, 2024


Summary


Performance

ACAD Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACADcash flowmetrics:

TTM CFI

-$30.54 M
+$122.50 M+80.05%

December 31, 2024


Summary


Performance

ACAD TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACADcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ACAD Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-195.4%+10000.0%-195.4%
3 y3 years+57.0%+70.7%+57.0%
5 y5 years+81.6%+158.4%+81.6%

ACAD Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-141.7%+57.0%-36.5%+162.9%-118.8%+82.5%
5 y5-year-115.9%+81.6%-36.5%+158.4%-115.8%+88.2%
alltimeall time-115.9%+88.3%-36.5%+158.4%-115.8%+88.9%

ACADIA Pharmaceuticals Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2024
-$30.54 M(-195.4%)
$122.15 M(-248.1%)
-$30.54 M(-80.0%)
Sep 2024
-
-$82.46 M(+46.7%)
-$153.03 M(+319.6%)
Jun 2024
-
-$56.19 M(+300.3%)
-$36.47 M(-79.1%)
Mar 2024
-
-$14.04 M(+3945.8%)
-$174.56 M(-645.5%)
Dec 2023
$32.00 M(-56.3%)
-$347.00 K(-101.0%)
$32.00 M(+119.2%)
Sep 2023
-
$34.11 M(-117.6%)
$14.60 M(-458.5%)
Jun 2023
-
-$194.28 M(-200.9%)
-$4.07 M(-103.0%)
Mar 2023
-
$192.52 M(-1184.7%)
$134.41 M(+83.5%)
Dec 2022
$73.24 M(-203.0%)
-$17.75 M(-214.9%)
$73.24 M(-54.9%)
Sep 2022
-
$15.44 M(-127.7%)
$162.54 M(-1862.1%)
Jun 2022
-
-$55.80 M(-142.5%)
-$9.22 M(-131.4%)
Mar 2022
-
$131.34 M(+83.6%)
$29.37 M(-141.3%)
Dec 2021
-$71.10 M(-136.9%)
$71.55 M(-145.8%)
-$71.10 M(-72.6%)
Sep 2021
-
-$156.32 M(+808.5%)
-$259.61 M(-622.3%)
Jun 2021
-
-$17.21 M(-155.7%)
$49.71 M(-74.3%)
Mar 2021
-
$30.88 M(-126.4%)
$193.78 M(+0.7%)
Dec 2020
$192.51 M(-216.1%)
-$116.96 M(-176.4%)
$192.51 M(+91.9%)
Sep 2020
-
$152.99 M(+20.6%)
$100.32 M(-334.7%)
Jun 2020
-
$126.86 M(+328.5%)
-$42.75 M(-73.1%)
Mar 2020
-
$29.61 M(-114.2%)
-$158.99 M(-4.1%)
Dec 2019
-$165.84 M(+132.0%)
-$209.14 M(-2207.7%)
-$165.84 M(+13.9%)
Sep 2019
-
$9.92 M(-6.6%)
-$145.64 M(+17.7%)
Jun 2019
-
$10.63 M(-53.3%)
-$123.78 M(-10.5%)
Mar 2019
-
$22.76 M(-112.0%)
-$138.35 M(+93.5%)
Dec 2018
-$71.49 M(-177.3%)
-$188.95 M(-694.5%)
-$71.49 M(-171.9%)
Sep 2018
-
$31.78 M(-906.3%)
$99.37 M(+14.3%)
Jun 2018
-
-$3.94 M(-104.4%)
$86.92 M(-32.7%)
Mar 2018
-
$89.62 M(-595.3%)
$129.16 M(+39.7%)
Dec 2017
$92.47 M(-135.3%)
-$18.09 M(-193.6%)
$92.47 M(-48.5%)
Sep 2017
-
$19.33 M(-49.5%)
$179.71 M(+3187.7%)
Jun 2017
-
$38.30 M(-27.6%)
$5.47 M(-113.6%)
Mar 2017
-
$52.94 M(-23.4%)
-$40.29 M(-84.6%)
Dec 2016
-$261.92 M(-277.5%)
$69.14 M(-144.6%)
-$261.92 M(-4.5%)
Sep 2016
-
-$154.91 M(+1976.5%)
-$274.34 M(+146.9%)
Jun 2016
-
-$7.46 M(-95.6%)
-$111.12 M(+86.5%)
Mar 2016
-
-$168.70 M(-397.4%)
-$59.60 M(-140.4%)
Dec 2015
$147.57 M(-269.1%)
$56.73 M(+582.8%)
$147.57 M(+12.4%)
Sep 2015
-
$8.31 M(-81.1%)
$131.32 M(-18.9%)
Jun 2015
-
$44.06 M(+14.5%)
$161.89 M(+221.8%)
Mar 2015
-
$38.47 M(-4.9%)
$50.31 M(-157.6%)
Dec 2014
-$87.27 M
$40.48 M(+4.1%)
-$87.27 M(-26.2%)
Sep 2014
-
$38.87 M(-157.6%)
-$118.21 M(-26.6%)
Jun 2014
-
-$67.51 M(-31.9%)
-$161.02 M(-16.2%)
DateAnnualQuarterlyTTM
Mar 2014
-
-$99.11 M(-1138.8%)
-$192.13 M(+52.4%)
Dec 2013
-$126.10 M(+394.0%)
$9.54 M(-342.0%)
-$126.10 M(-26.1%)
Sep 2013
-
-$3.94 M(-96.0%)
-$170.70 M(+0.7%)
Jun 2013
-
-$98.62 M(+198.1%)
-$169.50 M(+171.2%)
Mar 2013
-
-$33.09 M(-5.6%)
-$62.49 M(+144.8%)
Dec 2012
-$25.53 M(-526.9%)
-$35.05 M(+1177.5%)
-$25.53 M(-291.3%)
Sep 2012
-
-$2.74 M(-132.7%)
$13.34 M(-35.1%)
Jun 2012
-
$8.39 M(+116.5%)
$20.56 M(+10.6%)
Mar 2012
-
$3.88 M(+1.6%)
$18.59 M(+210.9%)
Dec 2011
$5.98 M(-664.2%)
$3.81 M(-14.8%)
$5.98 M(-206.9%)
Sep 2011
-
$4.48 M(-30.3%)
-$5.60 M(-21.5%)
Jun 2011
-
$6.42 M(-173.5%)
-$7.13 M(-56.3%)
Mar 2011
-
-$8.73 M(+12.5%)
-$16.31 M(+1439.1%)
Dec 2010
-$1.06 M(-111.2%)
-$7.76 M(-363.7%)
-$1.06 M(-107.0%)
Sep 2010
-
$2.94 M(-206.6%)
$15.23 M(-33.3%)
Jun 2010
-
-$2.76 M(-142.4%)
$22.82 M(+378.0%)
Mar 2010
-
$6.52 M(-23.6%)
$4.77 M(-49.5%)
Dec 2009
$9.44 M(-86.5%)
$8.53 M(-19.0%)
$9.44 M(-24.1%)
Sep 2009
-
$10.53 M(-150.6%)
$12.45 M(-38.0%)
Jun 2009
-
-$20.80 M(-285.9%)
$20.09 M(-64.3%)
Mar 2009
-
$11.19 M(-3.0%)
$56.27 M(-19.3%)
Dec 2008
$69.71 M(-266.4%)
$11.53 M(-36.5%)
$69.71 M(+6.7%)
Sep 2008
-
$18.17 M(+18.2%)
$65.35 M(+48.0%)
Jun 2008
-
$15.38 M(-37.6%)
$44.17 M(-218.6%)
Mar 2008
-
$24.64 M(+243.4%)
-$37.24 M(-11.1%)
Dec 2007
-$41.90 M(+82.7%)
$7.17 M(-337.7%)
-$41.90 M(-12.9%)
Sep 2007
-
-$3.02 M(-95.4%)
-$48.11 M(+5.5%)
Jun 2007
-
-$66.03 M(-430.6%)
-$45.62 M(+1178.2%)
Mar 2007
-
$19.97 M(+1965.3%)
-$3.57 M(-84.4%)
Dec 2006
-$22.94 M(+244.9%)
$967.00 K(-283.1%)
-$22.94 M(+27.8%)
Sep 2006
-
-$528.00 K(-97.8%)
-$17.95 M(+349.7%)
Jun 2006
-
-$23.98 M(-4070.0%)
-$3.99 M(+27.2%)
Mar 2006
-
$604.00 K(-89.8%)
-$3.14 M(-52.8%)
Dec 2005
-$6.65 M(-9.9%)
$5.95 M(-55.7%)
-$6.65 M(+122.2%)
Sep 2005
-
$13.43 M(-158.1%)
-$2.99 M(-77.6%)
Jun 2005
-
-$23.13 M(+695.3%)
-$13.34 M(+2.3%)
Mar 2005
-
-$2.91 M(-130.3%)
-$13.04 M(+76.7%)
Dec 2004
-$7.38 M(-49.8%)
$9.61 M(+211.0%)
-$7.38 M(-56.6%)
Sep 2004
-
$3.09 M(-113.5%)
-$16.99 M(-15.4%)
Jun 2004
-
-$22.83 M(-930.0%)
-$20.08 M(-830.0%)
Mar 2004
-
$2.75 M
$2.75 M
Dec 2003
-$14.69 M(-481.7%)
-
-
Dec 2002
$3.85 M
-
-

FAQ

  • What is ACADIA Pharmaceuticals annual cash flow from investing activities?
  • What is the all time high annual CFI for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals annual CFI year-on-year change?
  • What is ACADIA Pharmaceuticals quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals quarterly CFI year-on-year change?
  • What is ACADIA Pharmaceuticals TTM cash flow from investing activities?
  • What is the all time high TTM CFI for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals TTM CFI year-on-year change?

What is ACADIA Pharmaceuticals annual cash flow from investing activities?

The current annual CFI of ACAD is -$30.54 M

What is the all time high annual CFI for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high annual cash flow from investing activities is $192.51 M

What is ACADIA Pharmaceuticals annual CFI year-on-year change?

Over the past year, ACAD annual cash flow from investing activities has changed by -$62.54 M (-195.44%)

What is ACADIA Pharmaceuticals quarterly cash flow from investing activities?

The current quarterly CFI of ACAD is $122.15 M

What is the all time high quarterly CFI for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high quarterly cash flow from investing activities is $192.52 M

What is ACADIA Pharmaceuticals quarterly CFI year-on-year change?

Over the past year, ACAD quarterly cash flow from investing activities has changed by +$122.50 M (+35301.73%)

What is ACADIA Pharmaceuticals TTM cash flow from investing activities?

The current TTM CFI of ACAD is -$30.54 M

What is the all time high TTM CFI for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high TTM cash flow from investing activities is $193.78 M

What is ACADIA Pharmaceuticals TTM CFI year-on-year change?

Over the past year, ACAD TTM cash flow from investing activities has changed by -$62.54 M (-195.44%)